ambenonium chloride has been researched along with benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohnal, V; Gunn-Moore, F; Holas, O; Horova, A; Komloova, M; Kuca, K; Musilek, K | 1 |
1 other study(ies) available for ambenonium chloride and benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide
| Article | Year |
|---|---|
Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
Topics: Acetylcholinesterase; Ambenonium Chloride; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Edrophonium; Humans; Kinetics; Molecular Dynamics Simulation; Myasthenia Gravis; Protein Binding; Quinolinium Compounds; Recombinant Proteins; Structure-Activity Relationship | 2011 |